Sasaki T - Search Results

1

[Hepatic artery pseudoaneurysm after endoscopic biliary stenting for pancreatic cancer].

Asayama N, Sasaki T, Serikawa M, Minami T, Okazaki A, Ishigaki T, Ishii Y, Mouri T, Yoshimi S, Tsuboi T, Fujino H, Chayama K. Asayama N, et al. Among authors: sasaki t. Nihon Shokakibyo Gakkai Zasshi. 2014 May;111(5):931-9. Nihon Shokakibyo Gakkai Zasshi. 2014. PMID: 24806237 Japanese.

2

Irsogladine malate up-regulates gap junctional intercellular communication between pancreatic cancer cells via PKA pathway.

Kawasaki Y, Tsuchida A, Sasaki T, Yamasaki S, Kuwada Y, Murakami M, Chayama K. Kawasaki Y, et al. Among authors: sasaki t. Pancreas. 2002 Nov;25(4):373-7. doi: 10.1097/00006676-200211000-00009. Pancreas. 2002. PMID: 12409832

3

Potential involvement of IL-8 and its receptors in the invasiveness of pancreatic cancer cells.

Kuwada Y, Sasaki T, Morinaka K, Kitadai Y, Mukaida N, Chayama K. Kuwada Y, et al. Among authors: sasaki t. Int J Oncol. 2003 Apr;22(4):765-71. Int J Oncol. 2003. PMID: 12632066

4

Expressions of angiogenic factors in pancreatic ductal carcinoma: a correlative study with clinicopathologic parameters and patient survival.

Kuwahara K, Sasaki T, Kuwada Y, Murakami M, Yamasaki S, Chayama K. Kuwahara K, et al. Among authors: sasaki t. Pancreas. 2003 May;26(4):344-9. doi: 10.1097/00006676-200305000-00006. Pancreas. 2003. PMID: 12717266

5

Prognostic value of p53 and Ki-67 expression in resected or biopsy specimens of bile duct carcinoma.

Murakami M, Sasaki T, Kuwada Y, Yamasaki S, Kuwahara K, Chayama K. Murakami M, et al. Among authors: sasaki t. Oncol Rep. 2003 Sep-Oct;10(5):1091-6. Oncol Rep. 2003. PMID: 12883663

6

Gemcitabine suppresses malignant ascites of human pancreatic cancer: correlation with VEGF expression in ascites.

Kuwahara K, Sasaki T, Kobayashi K, Noma B, Serikawa M, Iiboshi T, Miyata H, Kuwada Y, Murakami M, Yamasaki S, Kariya K, Morinaka K, Chayama K. Kuwahara K, et al. Among authors: sasaki t. Oncol Rep. 2004 Jan;11(1):73-80. Oncol Rep. 2004. PMID: 14654905

7

Fas and Fas ligand: Expression and soluble circulating levels in bile duct carcinoma.

Murakami M, Sasaki T, Miyata H, Yamasaki S, Kuwahara K, Chayama K. Murakami M, et al. Among authors: sasaki t. Oncol Rep. 2004 Jun;11(6):1183-6. Oncol Rep. 2004. PMID: 15138553

8

Induction of apoptosis by ionizing radiation and CI-1033 in HuCCT-1 cells.

Murakami M, Sasaki T, Yamasaki S, Kuwahara K, Miyata H, Chayama K. Murakami M, et al. Among authors: sasaki t. Biochem Biophys Res Commun. 2004 Jun 18;319(1):114-9. doi: 10.1016/j.bbrc.2004.04.153. Biochem Biophys Res Commun. 2004. PMID: 15158449

9

[Management of diagnosis for biliary tract cancer].

Noma B, Sasaki T, Serikawa M, Kuwahara K, Chayama K. Noma B, et al. Among authors: sasaki t. Nihon Rinsho. 2006 Jan;64 Suppl 1:426-30. Nihon Rinsho. 2006. PMID: 16457298 Review. Japanese. No abstract available.

10

The effects of ZD1839 (Iressa), a highly selective EGFR tyrosine kinase inhibitor, as a radiosensitiser in bile duct carcinoma cell lines.

Miyata H, Sasaki T, Kuwahara K, Serikawa M, Chayama K. Miyata H, et al. Among authors: sasaki t. Int J Oncol. 2006 Apr;28(4):915-21. Int J Oncol. 2006. PMID: 16525641

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9,352 results

Search Page

Filters